Aliphatic Polyurethane Diffusion Barriers for In Vivo Sensors

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing implantable biosensors face challenges in accurately measuring physiologically relevant analyte concentrations due to issues with diffusion barriers that either limit the measurement range or allow toxic components to elute into the body, and there is a need for a biocompatible membrane that prevents interference and maintains accurate analyte concentration measurements.

Innovation Solution

A sensor device with an electrode system using an aliphatic polyurethane diffusion barrier with a molecular weight cut-off (MWCO) of < 10 kDa, which stabilizes analyte concentration and prevents the passage of toxic components, while maintaining sensitivity over time through controlled manufacturing processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If a diffusion barrier is used to extend the measurement range and reduce analyte consumption, then the measurement accuracy is improved, but toxic components may elute into the patient body

Engineering Contradiction:
Improvemeasurement accuracyVSAvoidtoxic component elution
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent employs a composite membrane structure combining multiple materials with complementary properties: an outer layer for biocompatibility and toxin rejection, and an inner layer for analyte permeability. This composite approach allows the diffusion barrier to simultaneously extend measurement range while preventing toxic component elution into the patient body.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The membrane is designed with spatially varying properties - different regions have different permeability characteristics tailored to specific functions. The outer surface possesses biocompatible properties to prevent immune response and toxin release, while the inner region maintains high analyte permeability for accurate measurement, thus resolving the contradiction between measurement accuracy and safety.

Inventive Principle:
Principle #3Local quality

2Measurement precision

If the diffusion barrier reduces analyte consumption to improve measurement correctness, then the in-vivo concentration accuracy is improved, but the measurement range may be limited

Engineering Contradiction:
Improvein-vivo concentration accuracyVSAvoidmeasurement range
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent utilizes controlled changes in membrane parameters including thickness, porosity, and material composition to optimize the balance between analyte consumption reduction and measurement range extension. By adjusting these parameters, the diffusion barrier maintains high analyte concentration accuracy while accommodating a broader range of analyte concentrations.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If screen printing paste components are added to create a functional working electrode, then the electrode functionality is improved, but the paste nature changes substantially

Engineering Contradiction:
Improveelectrode functionalityVSAvoidpaste composition stability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent incorporates all necessary functional components (enzymes, mediators, conductive materials) into the screen printing paste formulation during the manufacturing stage. This preliminary incorporation ensures that the paste maintains its applicability and handling properties while already containing the complete functional electrode system, thus resolving the contradiction between electrode functionality and manufacturing ease.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The aliphatic polyurethane diffusion barrier effectively extends the measurement range, reduces analyte consumption, and maintains sensor accuracy by stabilizing local analyte concentration, minimizing sensitivity loss over three months and one year.

Implementation Method 1

a diffusion barrier that controls diffusion from the exterior of the electrode system to the immobilized enzyme molecules

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

The diffusion barrier comprises an aliphatic polyurethane with a molecular weight cut-off (MWCO) of < 10 kDa, which stabilizes analyte concentration and prevents the passage of toxic components

Methodology Applied
Scientific EffectPermeation: Permeation

Data Source

PatentEP3950952B1Sensor device for determining the concentration of an analyte under in-vivo conditions and process of manufacturing
Publication Date: 2025.10.22 ROCHE DIABETES CARE GMBH
  • EP3950952B1 patent drawingFigure 1
  • EP3950952B1 patent drawingFigure 2
  • EP3950952B1 patent drawingFigure 3

AI summary

The disclosure refers to a sensor device for determining the concentration of an analyte under in-vivo conditions, comprising an electrode system having an electrode with immobilized enzyme molecules and a diffusion barrier that controls diffusion from the exterior of the electrode system to the immobilized enzyme molecules, wherein the diffusion barrier comprises an aliphatic polyurethane. Further, a process of manufacturing a sensor device is provided.